Secondary prevention antibiotic treatment trials for coronary artery disease.


Considerable interest was generated in the possible causative role of Chlamydia pneumoniae in coronary artery disease (CAD) by the publication of a small pilot study in London of antibiotic treatment of CAD that reduced coronary events.1 Persons familiar with antibiotic treatment of chlamydia were skeptical that the brief treatment schedule in the London… (More)


  • Presentations referencing similar topics